Skip to main content

and
Your search also matched 7 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

A Study of the Comparative Evaluation System of the Lower-Limb Exoskeleton

Include preview-only content
  1. Article

    Open Access

    Correction: characteristics of insulin resistance in Korean adults from the perspective of circadian and metabolic sensing genes

    Miso S. Park, Siwoo Lee, Younghwa Baek, Juho Lee, Sang-Soo Park in Genes & Genomics (2024)

  2. Article

    Open Access

    Characteristics of insulin resistance in Korean adults from the perspective of circadian and metabolic sensing genes

    The biological clock allows an organism to anticipate periodic environmental changes and adjust its physiology and behavior accordingly.

    Miso S. Park, Siwoo Lee, Younghwa Baek, Juho Lee, Sang-Soo Park in Genes & Genomics (2023)

  3. Article

    Open Access

    Synergistic effect of YOD1 and USP21 on the Hippo signaling pathway

    Deubiquitinating enzymes (DUBs) comprise a family of proteases responsible for cleaving the peptide or isopeptide bond between ubiquitin and its substrate proteins. Ubiquitin is essential for regulating divers...

    Sang-Soo Park, Kwang-Hyun Baek in Cancer Cell International (2023)

  4. Article

    Open Access

    Ramifications of POU4F3 variants associated with autosomal dominant hearing loss in various molecular aspects

    POU4F3, a member of the POU family of transcription factors, commonly causes autosomal dominant deafness. Exome sequencing was used to identify four novel variants in POU4F3 (NM_002700.2), including c.564dupA: p....

    Sang-Yeon Lee, Min Young Kim, ** Hee Han, Sang Soo Park, Ye** Yun in Scientific Reports (2023)

  5. Article

    Open Access

    Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations

    Mitogen-activated protein kinases (MEK 1/2) are central components of the RAS signalling pathway and are attractive targets for cancer therapy. These agents continue to be investigated in KRAS mutant colon cancer...

    Jai-Hee Moon, Seung-Woo Hong, Jeong Eun Kim, Jae-Sik Shin in British Journal of Cancer (2019)